Ortin Global Limited (NSE:ORTINGLOBE) — Market Cap & Net Worth
Market Cap & Net Worth: Ortin Global Limited (ORTINGLOBE)
Ortin Global Limited (NSE:ORTINGLOBE) has a market capitalization of $1.36 Million (Rs126.04 Million) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #30023 globally and #1686 in its home market, demonstrating a 5.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ortin Global Limited's stock price Rs15.50 by its total outstanding shares 8131392 (8.13 Million). Analyse Ortin Global Limited (ORTINGLOBE) cash conversion ratio to see how efficiently the company converts income to cash.
Ortin Global Limited Market Cap History: 2025 to 2026
Ortin Global Limited's market capitalization history from 2025 to 2026. Data shows growth from $1.21 Million to $1.36 Million (0.00% CAGR).
Ortin Global Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ortin Global Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.35x
Ortin Global Limited's market cap is 0.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.21 Million | $3.42 Million | -$8.46 Million | 0.35x | N/A |
Competitor Companies of ORTINGLOBE by Market Capitalization
Companies near Ortin Global Limited in the global market cap rankings as of May 4, 2026.
Key companies related to Ortin Global Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Ortin Global Limited Historical Marketcap From 2025 to 2026
Between 2025 and today, Ortin Global Limited's market cap moved from $1.21 Million to $ 1.36 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.36 Million | +12.24% |
| 2025 | Rs1.21 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Ortin Global Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.36 Million USD |
| MoneyControl | $1.36 Million USD |
| MarketWatch | $1.36 Million USD |
| marketcap.company | $1.36 Million USD |
| Reuters | $1.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more